.png)
Total amount raised
$1.5B
Latest funding date
2025-10-14
Location
Oura has raised significant funding across multiple rounds, with notable investors including Fidelity Management & Research Company, Dexcom, The Chernin Group, Elysian Park Ventures, and Forerunner Ventures. The company is dedicated to developing smart rings that offer comprehensive health monitoring, including fitness, stress management, and sleep tracking.
Keep reading to explore the intricacies of Oura's fundraising journey and the investors backing this innovative platform.
Oura has raised significant funding across multiple rounds, with notable investors including Fidelity Management & Research Company, Dexcom, The Chernin Group, Elysian Park Ventures, and Forerunner Ventures. The company is dedicated to developing smart rings that offer comprehensive health monitoring, including fitness, stress management, and sleep tracking.
Keep reading to explore the intricacies of Oura's fundraising journey and the investors backing this innovative platform.
What Is Oura?
Oura, founded in 2013 by Markku Koskela and Petteri Lahtela, is a health and wellness technology company headquartered in Oulu, Finland. The company specializes in developing wearable rings that monitor sleep, stress, fitness, and overall health metrics.
Operating in the health care, mobile apps, and wearables industries, Oura has grown to employ between 251 and 500 people. The Oura Ring, their flagship product, is designed for all-day wear and provides users with detailed health insights through an accompanying app.
How Much Funding Has Oura Raised?
- Seed Round
- Amount Raised: $2.3M (USD)
- Date: November 2015
- Lead Investors: Lifeline Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop the initial prototype and launch the first version of the Oura Ring.
- Series A
- Amount Raised: €5M (~$5.3M USD)
- Date: November 2016
- Lead Investors: Joi Ito, Jaan Tallinn
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale production and expand market reach of the Oura Ring.
- Series A Extension
- Amount Raised: $5.8M (USD)
- Date: July 2018
- Lead Investors: Bold Capital Partners, Tesi (Finnish Industry Investment)
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To enhance product features and improve the accompanying app.
- Series B (Celebrity Round)
- Amount Raised: ~$5.7M (USD)
- Date: December 2018
- Lead Investors: MSD Capital (Michael Dell)
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop the technology and expand the team; brought total funding to over $20M at the time.
- Series B
- Amount Raised: $28M (USD)
- Date: March 2020
- Lead Investors: Forerunner Ventures, Gradient Ventures, Square
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To accelerate growth and enter new markets.
- Series C
- Amount Raised: $100M (USD)
- Date: May 2021
- Lead Investors: The Chernin Group (TCG), Elysian Park Ventures, Temasek, JAZZ Venture Partners, Eisai
- Valuation at Round: ~$800M
- Motivation Behind the Round: To scale operations and enhance product offerings.
- Series D (Tranche 1)
- Amount Raised: $75M (USD)
- Date: November 2024
- Lead Investors: Dexcom
- Valuation at Round: ~$5B
- Motivation Behind the Round: Strategic partnership to integrate Dexcom's glucose data with Oura's health metrics.
- Series D (Tranche 2)
- Amount Raised: $125M (USD)
- Date: December 2024
- Lead Investors: Fidelity Management & Research Company
- Valuation at Round: $5.2B
- Motivation Behind the Round: To expand product offerings and accelerate global growth.
- Debt Financing
- Amount Raised: $250M (USD)
- Date: September 2025
- Lead Investors: JPMorgan Chase, Goldman Sachs, Bank of America, Barclays, Citi, Wells Fargo
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support operations and growth ahead of Series E equity raise.
- Series E
- Amount Raised: $900M (USD)
- Date: October 14, 2025
- Lead Investors: Fidelity Management & Research Company
- Participants: ICONIQ Capital, Whale Rock Capital Management, Atreides Management
- Valuation at Round: ~$11B
- Motivation Behind the Round: To accelerate AI and product innovation, expand global distribution, and invest in new health features.
Total Amount Raised: at least $1.5B based on disclosed funding. Current Valuation: ~$11B.
Key Investors
- Fidelity Management & Research Company
- Details: Fidelity is a multinational financial services corporation known for its investment management. Fidelity led the $125M closing tranche of Oura's Series D in December 2024 and led the $900M Series E in October 2025.
- Investment Focus Areas: Financial services, technology, healthcare
- Notable Investments: Oura
- Dexcom
- Details: Dexcom is a leading company in continuous glucose monitoring technology. Dexcom invested $75M in Oura's Series D in November 2024, forming a strategic partnership to integrate glucose data with the Oura Ring.
- Investment Focus Areas: Glucose monitoring, health metrics integration
- Notable Investments: Oura
- ICONIQ Capital
- Details: ICONIQ Capital is a multi-family office and investment firm that participated as a significant new investor in Oura's Series E round in October 2025.
- Investment Focus Areas: Technology, growth equity
- Notable Investments: Not publicly disclosed
- Elysian Park Ventures
- Details: Elysian Park Ventures is the private investment arm of the Los Angeles Dodgers ownership group. They invested in Oura during the Series C round in May 2021.
- Investment Focus Areas: Sports, technology, health and wellness
- Notable Investments: Not publicly disclosed
- The Chernin Group (TCG)
- Details: TCG is an investment firm focused on media, technology, and consumer brands. They co-led Oura's Series C round in May 2021.
- Investment Focus Areas: Media, technology, consumer brands
- Notable Investments: Not publicly disclosed
- Forerunner Ventures
- Details: Forerunner Ventures is a venture capital firm that invests in consumer-focused companies. They co-led Oura's Series B round in March 2020 and participated in the Series C.
- Investment Focus Areas: Consumer, retail, technology
- Notable Investments: Not publicly disclosed
What's Next for Oura?
Oura's future looks promising with significant opportunities on the horizon. The integration with Dexcom's glucose monitoring data could revolutionize health tracking, positioning Oura as a leader in the noninvasive glucose monitoring market. With an expected $500 million in sales next year, the company is poised for substantial growth.
Given its strong market position and recent $75 million Series D funding, Oura is well-placed to attract further investment. However, the company will need to navigate challenges such as competition from major players like Apple and ensuring the successful integration of new technologies.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Oura and gather other critical business insights. Sign up for free and start making data-driven decisions today.
